Inhibitory effects of bile acids and synthetic farnesoid X receptor agonists on rotavirus replication

Yunjeong Kim1, Kyeong-Ok Chang

  • 1Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, 1800 Denison Avenue, Manhattan, KS 66506, USA. ykim@vet.ksu.edu

Journal of Virology
|September 30, 2011
PubMed

Insights

Bile acids and farnesoid X receptor (FXR) agonists reduce rotavirus replication by regulating lipid synthesis. This study shows potential therapeutic targets for developing new antiviral drugs against rotavirus infection.

Area of Science:

  • Virology
  • Biochemistry
  • Pharmacology

Background:

  • Rotaviruses cause severe gastroenteritis in children globally.
  • No specific antiviral drugs are currently available for rotavirus infection.
  • Lipid homeostasis is crucial for rotavirus replication.

Purpose of the Study:

  • To investigate the effect of bile acids and farnesoid X receptor (FXR) agonists on rotavirus replication.
  • To explore the association between cellular lipid levels and rotavirus replication.
  • To evaluate the therapeutic potential of FXR agonists against rotavirus infection.

Main Methods:

  • Cell culture experiments to assess rotavirus replication.
  • Treatment with bile acids (CDCA, DCA) and synthetic FXR agonists (GW4064).
  • Measurement of intracellular triglyceride levels.
  • In vivo study using a mouse model of rotavirus infection.

Main Results:

  • Rotavirus infection significantly increased intracellular triglyceride levels.
  • CDCA, DCA, and GW4064 dose-dependently reduced rotavirus replication in cell culture.
  • Reduced viral replication correlated with FXR pathway activation and decreased triglyceride levels (r(2) = 0.95).
  • Oral CDCA administration significantly reduced fecal rotavirus shedding in mice.

Conclusions:

  • Bile acids and FXR agonists effectively suppress rotavirus replication.
  • The mechanism involves downregulating lipid synthesis pathways disrupted by rotavirus infection.
  • FXR agonists represent promising therapeutic targets for rotavirus antiviral development.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...